Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
dermal absorption in vivo
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Non GLP and non-guideline compliant study

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
1974
Report date:
1974
Reference Type:
publication
Title:
Bronidox, a new preserving agent for the cosmetics: properties and toxicological-dermatological assays
Author:
M. Potokar, et al.
Year:
1976
Bibliographic source:
Fette, Seifen, Anstrichmittel, Jahrgang 78, Nr. 7, 269-276

Materials and methods

Test guideline
Qualifier:
no guideline followed
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
5-bromo-5-nitro-1,3-dioxane
EC Number:
250-001-7
EC Name:
5-bromo-5-nitro-1,3-dioxane
Cas Number:
30007-47-7
Molecular formula:
C4H6BrNO4
IUPAC Name:
5-bromo-5-nitro-1,3-dioxane

Test animals

Species:
human
Sex:
male

Administration / exposure

Vehicle:
other: oil in water cream
Duration of exposure:
4 hours
Doses:
0.05%
Details on study design:
- Number of probands: 5 probands per dose, no clinical treatment, normal food.
- Age: 27 - 34 years
- Weight: 63 - 83 kg

APPLICATION OF DOSE: 2 g oil/water cream= 1 mg test substance

TEST SITE
- Preparation of test site: on the back
- Area of exposure: 20 x 30 cm
- Control: only vehicle (oil in water cream), next to the treated area

REMOVAL OF TEST SUBSTANCE
- Washing procedures and type of cleansing agent: After 4 hours with alcohol

SAMPLE COLLECTION
- Collection of urine: 1, 2, 3, 4, 8 and 24 hours

ANALYSIS
- Method type(s) for identification: GC of the washed test substance

Results and discussion

Percutaneous absorption
Key result
Time point:
24 h
Dose:
0.05%
Parameter:
percentage
Absorption:
ca. 50 %

Applicant's summary and conclusion